Lilly announces transitions in executive leadership

Core Insights - Eli Lilly and Company is undergoing executive leadership transitions to enhance long-term growth and ensure its medicines reach millions globally [1][2] Leadership Changes - Ilya Yuffa will transition to lead Lilly USA and Global Customer Capabilities, focusing on U.S. business operations and upcoming product launches [3] - Patrik Jonsson will take on the role of leading Lilly International, leveraging his experience in cardiometabolic health and U.S. markets to drive international growth [4] - Kenneth Custer has been promoted to lead Lilly Cardiometabolic Health, bringing 16 years of experience and a strong background in sales, marketing, and research [5] Growth Strategy - Lilly has seen significant growth in the U.S. and cardiometabolic health sectors and anticipates continued expansion in these areas [2] - The leadership changes are aimed at creating additional focus to reach the next level of growth and advance the company's long-term strategy [6]